Literature DB >> 11266089

Expression and functional significance of CTLA-4, a negative regulator of T cell activation.

A Kosmaczewska1, L Ciszak, D Boćko, I Frydecka.   

Abstract

The generation of an effective immune response involves antigen-specific T cell expansion and differentiation of effector function. T cell activation requires at least two distinct signals, including signaling via the antigen-specific T cell receptor (TCR) and a costimulatory pathway. Antigen stimulation of T cells can lead either to a productive immune response, characterized by proliferation, differentiation, clonal expansion and effector function, or, in the absence of an appropriate costimulation, to a state of long-lasting unresponsiveness, termed anergy. Anergic T cells fail to proliferate and secrete cytokines in response to secondary stimulation. The interaction between the costimulatory molecule CD28 on T cells and members of the B7 family on antigen-presenting cell results in upregulation of T cell proliferation and cytokine production and induces the expression of the anti-apoptotic protein Bcl-xl. Based of these findings, the two-signal requirement model for T cell activation is generally accepted today. The negative regulatory mechanisms during T cell activation are not well understood, but they are crucial for the maintainance of lymphocyte homeostasis. For several years the functional role of the enigmatic CD28 homologue cytotoxic T lymphocyte antigen-4 (CTLA-4) in T cell activation has been both obscure and controversial. CTLA-4 was initially supposed to provide a costimulatory signal in conjunction with TCR/CD3 signaling. Today we know that CD28 and CTLA-4 molecules may have diametrically opposed functions: signaling via CD28, in conjunctive with TCR, is required for T cell activation, while signaling via CTLA-4 is a negative signal that inhibits T cell proliferation. How the T cell integrates signals through the TCR/CD3 complex, CD28 and CTLA-4 to initiate, maintain and terminate antigen-specific immune response is in fact not fully clarified. In this review, we will focus on the emerging role of CTLA-4 as a negative regulator of T lymphocyte activation and its role in the dynamic interplay of activatory and inhibitory signals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11266089

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  11 in total

1.  Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians.

Authors:  Jihen Benmansour; Mouna Stayoussef; Fayza A Al-Jenaidi; Mansoor H Rajab; Chiheb B Rayana; Hichem B Said; Touhami Mahjoub; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

2.  Identification of Spindle and Kinetochore-Associated Family Genes as Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment.

Authors:  Yi Liu; Zong-Rui Jin; Xing Huang; Ye-Cheng Che; Qin Liu
Journal:  Front Oncol       Date:  2020-11-02       Impact factor: 6.244

3.  The role of CTLA-4 exon-1 49 A/G polymorphism and soluble CTLA-4 protein level in egyptian patients with Behçet's disease.

Authors:  Sahar M Abdel Galil; Hoda A Hagrass
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

Review 4.  General and Specific Genetic Polymorphism of Cytokines-Related Gene in AITD.

Authors:  Chen Xiaoheng; Mei Yizhou; He Bei; Li Huilong; Wang Xin; Hu Rui; Li Lu; Ding Zhiguo
Journal:  Mediators Inflamm       Date:  2017-01-04       Impact factor: 4.711

Review 5.  New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.

Authors:  Isabel Corraliza-Gorjón; Beatriz Somovilla-Crespo; Silvia Santamaria; Jose A Garcia-Sanz; Leonor Kremer
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

6.  Distribution of Cytotoxic T Lymphocyte-Associated Antigen-4 Promoter Polymorphisms in Taiwanese Patients with Type 2 Diabetes Mellitus.

Authors:  Yung-Luen Shih; Hsu-Feng Lu; Chiao-Wan Hsiao; Kuo-Ting Ho; Pei-Chi Chen; Chien-Ning Huang; Yuanmay Chang; Shang-Jyh Kao; Ming-Yuh Shiau; Yih-Hsin Chang
Journal:  Int J Med Sci       Date:  2018-02-12       Impact factor: 3.738

7.  Associations between cytotoxic T-lymphocyte-associated antigen 4 gene polymorphisms and diabetes mellitus: a meta-analysis of 76 case-control studies.

Authors:  Min Chen; ShuMin Li
Journal:  Biosci Rep       Date:  2019-05-15       Impact factor: 3.840

8.  On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases.

Authors:  M R Bernsen; L Håkansson; B Gustafsson; L Krysander; B Rettrup; D Ruiter; A Håkansson
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

9.  Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha.

Authors:  Janina Krupińska; Waldemar Urbanowicz; Mariusz Kaczmarczyk; Grzegorz Kulig; Elżbieta Sowińska-Przepiera; Elżbieta Andrysiak-Mamos; Anhelli Syrenicz
Journal:  Thyroid Res       Date:  2012-10-16

Review 10.  NK Cell-Based Immune Checkpoint Inhibition.

Authors:  Muhammad Khan; Sumbal Arooj; Hua Wang
Journal:  Front Immunol       Date:  2020-02-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.